Differential synovial tissue expression of TLRs in seropositive and seronegative rheumatoid arthritis: A preliminary report

References

• Kourilovitch M, Galarza-Maldonado C, Ortiz-Prado E. Diagnosis and classification of rheumatoid arthritis. J Autoimmun. 2014; 48–49:26–30.
   PubMed Web of Science ®Google Scholar
• Gabriel SE, Michaud K. Epidemiological studies in incidence, prevalence, mortality, and comorbidity of the rheumatic diseases. Arthritis Res Ther. 2009;11:229.
   PubMed Web of Science ®Google Scholar
• Sokka T. Work disability in early rheumatoid arthritis. Clin Exp Rheumatol. 2003;21:S71–S74.
   PubMed Web of Science ®Google Scholar
• Aletaha D, Neogi T, Silman AJ, et al. 2010 rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Ann Rheum Dis. 2010;69:1580–1588.
   PubMed Web of Science ®Google Scholar
• Ajeganova S, Huizinga TW. Rheumatoid arthritis: seronegative and seropositive RA: alike but different? Nat Rev Rheumatol. 2015;11:8–9.
   PubMed Web of Science ®Google Scholar
• Derksen VFAM, Huizinga TWJ, van der Woude D. The role of autoantibodies in the pathophysiology of rheumatoid arthritis. Semin Immunopathol. 2017;39:437–446.
   PubMed Web of Science ®Google Scholar
• Huang QQ, Pope RM. The role of Toll-like receptors in rheumatoid arthritis. Curr Rheumatol Rep. 2009;11:357–364.
   PubMedGoogle Scholar
• Joosten LA, Abdollahi-Roodsaz S, Dinarello CA, et al. Toll-like receptors and chronic inflammation in rheumatic diseases: new developments. Nat Rev Rheumatol. 2016;12:344–357.
   PubMed Web of Science ®Google Scholar
• Trinchieri G, Sher A. Cooperation of Toll-like receptor signals in innate immune defence. Nat Rev Immunol. 2007;7:179–190.
   PubMed Web of Science ®Google Scholar
• Aderem A, Ulevitch RJ. Toll-like receptors in the induction of the innate immune response. Nature. 2000;406:782–787.
   PubMed Web of Science ®Google Scholar
• Akira S, Takeda K, Kaisho T. Toll-like receptors: critical proteins linking innate and acquired immunity. Nat Immunol. 2001;2:675–680.
   PubMed Web of Science ®Google Scholar
• Tuomela J, Sandholm J, Kaakinen M, et al. DNA from dead cancer cells induces TLR9-mediated invasion and inflammation in living cancer cells. Breast Cancer Res Treat. 2013;142:477–487.
   PubMed Web of Science ®Google Scholar
• Radstake TR, Roelofs MF, Jenniskens YM, et al. Expression of Toll-like receptors 2 and 4 in rheumatoid synovial tissue and regulation by proinflammatory cytokines interleukin-12 and interleukin-18 via interferon-gamma. Arthritis Rheum. 2004;50:3856–3865.
   PubMed Web of Science ®Google Scholar
• Kyburz D, Rethage J, Seibl R, et al. Bacterial peptidoglycans but not CpG oligodeoxynucleotides activate synovial fibroblasts by Toll-like receptor signaling. Arthritis Rheum. 2003;48:642–650.
   PubMed Web of Science ®Google Scholar
• Brentano F, Schorr O, Gay RE, et al. RNA released from necrotic synovial fluid cells activates rheumatoid arthritis synovial fibroblasts via Toll-like receptor 3. Arthritis Rheum. 2005;52:2656–2665.
   PubMed Web of Science ®Google Scholar
• Takeuchi O, Akira S. Toll-like receptors; their physiological role and signal transduction system. Int Immunopharmacol. 2001;1:625–635.
   PubMed Web of Science ®Google Scholar
• Takeda K, Akira S. Roles of Toll-like receptors in innate immune responses. Genes Cells. 2001;6:733–742.
   PubMed Web of Science ®Google Scholar
• Abdollahi-Roodsaz S, Joosten LA, Helsen MM, et al. Shift from Toll-like receptor 2 (TLR-2) toward TLR-4 dependency in the erosive stage of chronic streptococcal cell wall arthritis coincident with TLR-4-mediated interleukin-17 production. Arthritis Rheum. 2008;58:3753–3764.
   PubMedGoogle Scholar
• Kim SJ, Chen Z, Chamberlain ND, et al. Angiogenesis in rheumatoid arthritis is fostered directly by Toll-like receptor 5 ligation and indirectly through interleukin-17 induction. Arthritis Rheum. 2013;65:2024–2036.
   PubMedGoogle Scholar
• Yarilina A, DiCarlo E, Ivashkiv LB. Suppression of the effector phase of inflammatory arthritis by double-stranded RNA is mediated by type I IFNs. J Immunol. 2007;178:2204–2211.
   PubMed Web of Science ®Google Scholar
• Wu HJ, Sawaya H, Binstadt B, et al. Inflammatory arthritis can be reined in by CpG-induced DC-NK cell cross talk. J Exp Med. 2007;204:1911–1922.
   PubMed Web of Science ®Google Scholar
• Hayashi T, Gray CS, Chan M, et al. Prevention of autoimmune disease by induction of tolerance to Toll-like receptor 7. Proc Natl Acad Sci U S A. 2009;106:2764–2769.
   PubMed Web of Science ®Google Scholar
• Raicevic G, Rouas R, Najar M, et al. Inflammation modifies the pattern and the function of Toll-like receptors expressed by human mesenchymal stromal cells. Hum Immunol. 2010;71:235–244.
   PubMed Web of Science ®Google Scholar
• Nurmenniemi S, Kuvaja P, Lehtonen S, et al. Toll-like receptor 9 ligands enhance mesenchymal stem cell invasion and expression of matrix metalloprotease-13. Exp Cell Res. 2010;316:2676–2682.
   PubMed Web of Science ®Google Scholar
• Methe H, Zimmer E, Grimm C, et al. Evidence for a role of Toll-like receptor 4 in development of chronic allograft rejection after cardiac transplantation. Transplantation. 2004; 78:1324–1331.
   PubMed Web of Science ®Google Scholar
• Penack O, Holler E, van den Brink MR. Graft-versus-host disease: regulation by microbe-associated molecules and innate immune receptors. Blood. 2010;115:1865–1872.
   PubMed Web of Science ®Google Scholar
• Mohammad Hosseini A, Majidi J, Baradaran B, et al. Toll-like receptors in the pathogenesis of autoimmune diseases. Adv Pharm Bull. 2015;5:605–614.
   PubMed Web of Science ®Google Scholar
• Orr C, Vieira-Sousa E, Boyle DL, et al. Synovial tissue research: a state-of-the-art review. Nat Rev Rheumatol. 2017;13:463–475.
   PubMed Web of Science ®Google Scholar
• Huhta H, Helminen O, Kauppila JH, et al. The expression of Toll-like receptors in normal human and murine gastrointestinal organs and the effect of microbiome and cancer. J Histochem Cytochem. 2016;64:470–482.
   PubMed Web of Science ®Google Scholar
• Krenn V, Morawietz L, Haupl T, et al. Grading of chronic synovitis – a histopathological grading system for molecular and diagnostic pathology. Pathol Res Pract. 2002;198:317–325.
   PubMed Web of Science ®Google Scholar
• Turunen S, Koivula MK, Risteli L, et al. Anticitrulline antibodies can be caused by homocitrulline-containing proteins in rabbits. Arthritis Rheum. 2010;62:3345–3352.
   PubMed Web of Science ®Google Scholar
• Turunen S, Huhtakangas J, Nousiainen T, et al. Rheumatoid arthritis antigens homocitrulline and citrulline are generated by local myeloperoxidase and peptidyl arginine deiminases 2, 3 and 4 in rheumatoid nodule and synovial tissue. Arthritis Res Ther. 2016;18:239.
   PubMed Web of Science ®Google Scholar
• Tamaki Y, Takakubo Y, Hirayama T, Konttinen YT, et al. Expression of Toll-like receptors and their signaling pathways in rheumatoid synovitis. J Rheumatol. 2011;38:810–820.
   PubMed Web of Science ®Google Scholar
• Roelofs MF, Joosten LA, Abdollahi-Roodsaz S, et al. The expression of Toll-like receptors 3 and 7 in rheumatoid arthritis synovium is increased and costimulation of Toll-like receptors 3, 4, and 7/8 results in synergistic cytokine production by dendritic cells. Arthritis Rheum. 2005;52:2313–2322.
   PubMed Web of Science ®Google Scholar
• Ospelt C, Brentano F, Rengel Y, et al. Overexpression of Toll-like receptors 3 and 4 in synovial tissue from patients with early rheumatoid arthritis: Toll-like receptor expression in early and longstanding arthritis. Arthritis Rheum. 2008;58:3684–3692.
   PubMed Web of Science ®Google Scholar
• Turunen S, Koivula MK, Melkko J, et al. Different amounts of protein-bound citrulline and homocitrulline in foot joint tissues of a patient with anti-citrullinated protein antibody positive erosive rheumatoid arthritis. J Transl Med. 2013; 11:224.
   PubMed Web of Science ®Google Scholar
• McGarry T, Biniecka M, Gao W, et al. Resolution of TLR2-induced inflammation through manipulation of metabolic pathways in rheumatoid arthritis. Sci Rep. 2017; 7:43165.
   PubMed Web of Science ®Google Scholar
• West AP, Brodsky IE, Rahner C, et al. TLR signalling augments macrophage bactericidal activity through mitochondrial ROS. Nature. 2011;472:476–480.
   PubMed Web of Science ®Google Scholar
• Sokolove J, Zhao X, Chandra PE, et al. Immune complexes containing citrullinated fibrinogen costimulate macrophages via Toll-like receptor 4 and Fcγ receptor. Arthritis Rheum. 2011;63:53–62.
   PubMed Web of Science ®Google Scholar
• Lamphier MS, Sirois CM, Verma A, et al. Latz E: TLR9 and the recognition of self and non-self nucleic acids. Ann N Y Acad Sci. 2006; 1082:31–43.
   PubMed Web of Science ®Google Scholar
• Vitkov L, Hannig M, Minnich B, et al. Periodontal sources of citrullinated antigens and TLR agonists related to RA. Autoimmunity. 2018;51:304–309.
   PubMed Web of Science ®Google Scholar
• Chamberlain ND, Kim SJ, Vila OM, Volin MV, et al. Ligation of TLR7 by rheumatoid arthritis synovial fluid single strand RNA induces transcription of TNFα in monocytes. Ann Rheum Dis. 2013;72:418–426.
   PubMed Web of Science ®Google Scholar
• Stephenson RM, Lim CM, Matthews M, et al. TLR8 stimulation enhances cetuximab-mediated natural killer cell lysis of head and neck cancer cells and dendritic cell cross-priming of EGFR-specific CD8+ T cells. Cancer Immunol Immunother. 2013;62:1347–1357.
   PubMed Web of Science ®Google Scholar
• Takakubo Y, Tamaki Y, Hirayama T, Iwazaki K, et al. Inflammatory immune cell responses and Toll-like receptor expression in synovial tissues in rheumatoid arthritis patients treated with biologics or DMARDs. Clin Rheumatol. 2013;32:853–861.
   PubMed Web of Science ®Google Scholar
• Glass CK, Saijo K. Nuclear receptor transrepression pathways that regulate inflammation in macrophages and T cells. Nat Rev Immunol. 2010;10:365–376.
   PubMed Web of Science ®Google Scholar
• Helminen O, Huhta H, Leppanen J, et al. Nuclear localization of Toll-like receptor 5 in Barrett’s esophagus and esophageal adenocarcinoma is associated with metastatic behavior. Virchows Arch. 2016;469:465–470.
   PubMed Web of Science ®Google Scholar
• Huhta H, Helminen O, Lehenkari PP, et al. Toll-like receptors 1, 2, 4 and 6 in esophageal epithelium, Barrett’s esophagus, dysplasia and adenocarcinoma. Oncotarget. 2016;7:23658–23667.
   PubMedGoogle Scholar
• Nair A, Kanda V, Bush-Joseph C, et al. Synovial fluid from patients with early osteoarthritis modulates fibroblast-like synoviocyte responses to Toll-like receptor 4 and Toll-like receptor 2 ligands via soluble CD14. Arthritis Rheum. 2012;64:2268–2277.
   PubMed Web of Science ®Google Scholar